SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001356710-20-000003
Filing Date
2020-12-23
Accepted
2020-12-23 16:24:42
Documents
1
Period of Report
2020-12-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7775
  Complete submission text file 0001356710-20-000003.txt   9456
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7280 WESTPOINTE BLVD APT 831 ORLANDO FL 32835
Business Address
Weldon Steven W (Reporting) CIK: 0001356710 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-08092 | Film No.: 201412592